Completed
Comparative Effectiveness of Targeted Therapies in BRAF Positive Metastatic Melanoma in the US
NCT05260684
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Pfizer Investigational Site New York, United States